The case of parallel classification of biliary tract and pancreatic neoplasms

Modern Pathology

Volumn 9, Issue 8, 1996, Pages 828-837

  Longnecker, Daniel S ^a,b   Terhune, Pamela Guay ^a  

^a DARTMOUTH MEDICAL SCHOOL   (United States)

^b DARTMOUTH HITCHCOCK MEDICAL CENTER   (United States)

Author keywords

Bile duct carcinoma; Cholangiocarcinoma,; Classification of biliary and pancreatic tumors; Pancreatic tumors

Indexed keywords

ARTICLE; BILE DUCT CARCINOMA; CANCER CLASSIFICATION; HISTOLOGY; HUMAN; HUMAN TISSUE; ONCOGENE; PANCREAS CARCINOMA; PRIORITY JOURNAL;

BILIARY TRACT NEOPLASMS; GENES, TUMOR SUPPRESSOR; HUMANS; ONCOGENES; PANCREATIC NEOPLASMS; TUMOR MARKERS, BIOLOGICAL;

EID: 0029783370     PISSN: 08933952     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (64)

1. Albores-Saavedra J, Henson DE: Tumors of the Gallbladder and Extrahepatic Bile Ducts. Washington, DC, Armed Forces Institute of Pathology, 1986
2. Klöppel G, Solcia E, Longnecker DS, Capella C, Sobin LH: Histologic Typing of Tumours of the Exocrine Pancreas. New York, Springer-Verlag, 1996
3. Longnecker DS, Terhune PG: Carcinogenesis and pathology of carcinomas in the pancreas: Comparison with the biliary tract. In Biliary and Pancreatic Ductal Epithelia: Pathobiology and Pathophysiology, edited by Sirica AE, Longnecker DS, p 527. New York, Marcel Dekker, 1996
4. Albores-Saavedra J, Henson DE, Sobin LH: Histological Typing of Tumours of the Gallbladder and Extrahepatic Bile Ducts. New York, Springer-Verlag, 1991
5. Albores-Saavedra J, Henson DE, Sobin LH: The WHO histological classification of tumors of the gallbladder and extrahepatic bile ducts. A commentary on the second edition. Cancer 70:410, 1992
6. Henson DE, Albores-Saavedra J, Corle D: Carcinoma of the extrahepatic bile ducts. Histologic types, stage of disease, grade, and survival rates. Cancer 70:1498, 1992
7. Henson DE, Albores-Saavedra J, Corle D: Carcinoma of the gallbladder. Histologic types, stage of disease, grade, and survival rates. Cancer 70:1493, 1992
8. Anthony PP: Epidemiology, aetiology and pathology of bile duct tumours. In Cancer of the Bile Ducts and Pancreas, edited by Preece PE, Cuschieri A, Rosin RD, pp 1-26. Philadelphia, Saunders, 1989
9. Cubilla AL, Fitzgerald PJ: Tumors of the exocrine pancreas. In Atlas of Tumor Pathology, edited by Hartmann WH, Sobin LH, Series 2, Fascicle 19, p 83. Washington, D.C., Armed Forces Institute of Pathology, 1984
10. Klöppel G: Pathology of nonendocrine pancreatic tumors. In The Pancreas: Biology Pathobiology and Disease, edited by Go VLW, DiMagno EP, Gardner JD, et al., p 871. New York, Raven Press, 1993
11. Pour PM, Konishi Y, Klöppel G, Longnecker DS: Atlas of Exocrine Pancreatic Tumors. Tokyo, Springer-Verlag, 1994
12. Longnecker DS: Pancreas. In Anderson's Pathology, edited by Damjanov I, Linder J, p 1891. St. Louis, Mosby, 1996
13. Jesserun J, Albores-Saavedra J: Gallbladder and extrahepatic biliary ducts. In Anderson's Pathology, edited by Damjanov I, Linder J, p 1859. St. Louis, Mosby, 1996
14. Devaney K, Goodman ZD, Ishak KG: Hepatobiliary cystadenoma and cystadenocarcinoma. A light microscopic and immunohistochemical study of 70 patients. Am J Surg Pathol 18:1078, 1994
15. Thomas JA, Scriven MW, Puntis MC, Jasani B, Williams GT: Elevated serum CA19-9 levels in hepatobiliary cystadenoma with mesenchymal stroma. Two case reports with immunohistochemical confirmation. Cancer 70:1841, 1992
16. Peny MO, Noel JC, Gelin M, Deprez C, Verhest A: Hepatobiliary cystadenoma with mesenchymal stroma: Presentation of one case and review of the literature. Acta Gastroenterol Belg 55:364, 1992
17. Compagno D, Oertel JE: Mucinous cystic neoplasms with overt and latent malignancy. Am J Clin Pathol 69:573, 1978
18. Longnecker DS: Intraductal papillary-mucinous tumors of the pancreas. Arch Pathol Lab Med 119:197, 1995
19. Lind DS, Adolph V, Parker GA: Mucinous biliary cystadenoma: A case report and review of the literature. J Surg Oncol 51:207, 1992
20. Albores-Saavedra J, Vardaman CJ, Vuitch F: Non-neoplastic polypoid lesions and adenomas of the gallbladder. Pathol Annu 28:145, 1993
21. Sessa F, Solcia E, Capella C, et al.: Intraductal papillary-mucinous tumours represent a distinct group of pancreatic neoplasms: An investigation of tumour cell differentiation and K-ras, p53, and c-erb-E-2 abnormalities in 26 patients. Virchows Arch 425:357, 1994
22. Santini D, Campione O, Salerno A, et al.: Intraductal papillary-mucinous neoplasm of the pancreas. A clinicopathologic entity. Arch Pathol Lab Med 119:209, 1995
23. Yamaguchi K: Early bile duct carcinoma. Aust N Z J Surg 62:525, 1992
24. Holtkamp W, Reis HE: Papillomatosis of the bile ducts: Papilloma-carcinoma sequence. Am J Gastroenterol 89:2253, 1994
25. Satoh K, Ohtani H, Shimosegawa T, et al.: Infrequent stromal expression of gelatinase A and intact basement membrane in intraductal neoplasms of the pancreas. Gastroenterology 107:1488, 1994
26. Kirby RE, Lewandrowski KB, Southern JF, Compton CC, Warshaw AL: Relation of epidermal growth factor receptor and estrogen receptor-independent pS2 protein to the malignant transformation of mucinous cystic neoplasms of the pancreas. Arch Surg 130:69, 1995
27. Kim YI, Kim ST, Lee GK, Choi BI: Papillary cystic tumor of liver. Cancer 65:2740, 1990
28. Vardaman C, Albores-Saavedra J: Clear cell carcinomas of the gallbladder and extrahepatic bile ducts. Am J Surg Pathol 19:91, 1995
29. Haratake I, Yamada H, Horie A, Inokuma T: Giant cell tumor-like cholangiocarcinoma associated with systemic cholelithiasis. Cancer 69:2444, 1992
30. Abu-Farsakh H, Fraire AE: Adenocarcinoma and (extragonadal) choriocarcinoma of the gallbladder in a young woman. Hum Pathol 22:614, 1991
31. Pasanen PA, Eskelinen M, Partanen K, et al.: Clinical value of serum tumour markers CEA CA50 and CA242 in the distinction between malignant versus benign diseases causing jaundice and cholestasis: Results from a prospective study. Anticancer Res 12:1687, 1992
32. Nichols JC, Gores GJ, La Russo NF, et al.: Diagnostic role of serum CA19-9 for cholangiocarcinoma in patients with primary sclerosing cholangitis. Mayo Clin Proc 68:874, 1993
33. Terhune PG, Longnecker DS: Do oncogene and tumor suppressor gene abnormalities vary with type of carcinoma of the pancreas? J Hep Bil Pancr Surg 2:1, 1995
34. Caldas C, Kern SE: K-ras mutation and pancreatic adenocarcinoma: State of the art. Int J Pancreatol 18:1, 1995
35. Mecklin JP, Jarvinen HJ, Virolainen M: The association between cholangiocarcinoma and hereditary nonpolyposis colorectal carcinoma. Cancer 69:1112, 1992
36. Lynch HT, Smyrk T, Kern SE, et al.: Familial pancreatic cancer: A review. Semin Oncol 23:251, 1996
37. Fishel R, Lescoe MK, Rao MR, et al.: The human mutator gene homolog MSH2 and its association with hereditary nonpolyposis colon cancer. Cell 77:167, 1994
38. Leach FS, Nicolaides NC, Papadopoulos N, et al.: Mutations of a mutS homolog in hereditary nonpolyposis colorectal cancer. Cell 75:1215, 1993
39. Kinzler KW, Nilbert MC, Su LK, et al.: Identification of FAP locus genes from chromosome 5q21. Science 253:661, 1991
40. Nishisho I, Nakamura Y, Miyoshi Y, et al.: Mutations of chromosome 5q21 genes in FAP and colorectal cancer patients. Science 253:665, 1991
41. Miyoshi Y, Ando H, Nagase H, et al.: Germline mutations of the APC gene in 53 familial adenomatous polyposis patients. Proc Natl Acad Sci U S A 89:4452, 1992
42. Nakamura Y: The role of the adenomatous polyposis coli (APC) gene in human cancers. Adv Cancer Res 62:65, 1993
43. Elmore LW, Sirica AE: Phenotypic characterization of meta-plastic intestinal glands and ductular hepatocytes in cholangiofibrotic lesions rapidly induced in the caudate liver lobe of rats treated with furan. Cancer Res 51:5752, 1991
44. Haswell-Elkins MR, Satarug S, Tsuda M, et al.: Liver fluke infection and cholangiocarcinoma: Model of endogenous nitric oxide and extragastric nitrosation in human carcinogenesis. Mutat Res 305:241, 1994
45. Nishihara K, Tsuneyoshi M, Shimura H, Yasunami Y: Three synchronous carcinomas of the papilla of Vater, common bile duct and pancreas. Pathol Int 44:325, 1994
46. Manusco TF, El Attar AA: Cohort study of workers exposed to naphthyl-amine and benzidine. J Occup Med 9:227, 1967
47. Brown DP: Mortality of workers employed at organochlorine pesticide manufacturing plants: An update. Scand J Work Environ Health 18:155, 1992
48. Takayasu K, Kasugai H, Ikeya S, et al.: A clinical and radiologic study of primary liver cancer associated with extrahepatic primary cancer. Cancer 69:45, 1992
49. Klimstra DS, Longnecker DS: K-ras mutations in pancreatic ductal proliferative lesions (letter). Am J Pathol 145:1547, 1994
50. Furukawa T, Chiba R, Kobari M, et al.: Varying grades of epithelial atypia in the pancreatic ducts of humans: Classification based on morphometry and multivariate analysis and correlated with positive reactions of carcinoembryonic antigen. Arch Path Lab Med 118:227, 1994
51. Sirica AE, Gainey TW, Harrell MB, Caran N: Cholangiocarcinogenesis and biliary adaptation responses in hepatic injury. In Biliary and Pancreatic Ductal Epithelia: Pathobiology and Pathophysiology, edited by Sirica AE, Longnecker DS. New York, Marcel Dekker 1996
52. Bockman DE: Cells of origin of pancreatic cancer: Experimental animal tumors related to human pancreas. Cancer 47:1528, 1981
53. Reddy JK, Kanwar YS, Rao MS, et al.: Duct-like morphogenesis of Longnecker pancreatic acinar carcinoma cells maintained in vitro on seminiferous tubular basement membranes. Cancer Res 46:347, 1986
54. Pettengill OS, Faris RA, Bell RH Jr, Kuhlmann ET, Longnecker DS: Derivation of duct-like cell lines from transplantable acinar cell carcinoma of the rat pancreas. Am J Pathol 143:292, 1993
55. Sandgren EP, Quaife CJ, Paulovich AG, Palmiter RD, Brinster RL: Pancreatic tumor pathogenesis reflects the causative genetic lesion. Proc Natl Acad Sci U S A 88:93, 1991
56. Bhuiya MR, Nimura Y, Kamiya J, et al.: Clinicopathologic studies on perineural invasion of bile duct carcinoma. Ann Surg 215:344, 1992
57. Nagakawa T, Mori K, Nakano T, et al.: Perineural invasion of carcinoma of the pancreas and biliary tract. Br J Surg 80:619, 1993
58. Stemmermann G, Heffelfinger SC, Noffsinger A, et al.: The molecular biology of esophageal and gastric cancer and their precursors: Oncogenes, tumor suppressor genes, and growth factors. Hum Pathol 25:968, 1994
59. Hilton DA, West KP: c-erb-B-2 oncogene product expression and prognosis in gastric carcinoma. J Clin Pathol 45:454, 1992
60. Fearon ER: Molecular genetic studies of the adenoma-carcinoma sequence. Adv Int Med 39:123, 1994
61. Tal M, Wetzler Z, Josefberg Z, et al.: Sporadic amplification of the HER2/neu protooncogene in adenocarcinomas of various tissues. Cancer Res 48:1517, 1980
62. Van de Vijver MJ, Nusse R: The molecular biology of breast cancer. Biochim Biophys Acta 1072:33, 1991
63. Lindblom A: Familial breast cancer and genes involved in breast carcinogenesis. Breast Cancer Res Treat 34:171, 1995
64. Motojima K, Komuta K, Hiasa A, et al.: Evaluation of immunoreactivity to erbB-2 protein as a marker of prognosis in bile duct carcinoma. Nippon Geka Gakkai Zasshi 93:952, 1992